Reduced binding of3H-spiroperidol to lymphocyte in Wilson's disease
- 1 May 1984
- journal article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 69 (5) , 298-301
- https://doi.org/10.1111/j.1600-0404.1984.tb07816.x
Abstract
— Biochemical studies of CSF from patients with Wilson's disease (WD) have increased that alterations in the state of dopaminergic and serotoninergic systems are similar to those manifested in Parkinson's disease. Recently, the density of dopaminergic receptors on lymphocytes has been found to be diminished in Parkinson's disease. In the present study, 3H-spiroperidol binding was evaluated in lymphocytes acquired from 12 patients suffering from WD, as compared to blood donors. A significant decrease in the number of binding sites (Bmax) was observed in the lymphocytes of the WD patients. There was no clear relationship between clinical status, age and duration of the disease and the alterations in receptor density. The mechanism underlying the decrease in lymphocyte 3H-spiroperidol binding sites in WD demands clarification.Keywords
This publication has 7 references indexed in Scilit:
- [3H]spiroperidol binding on lymphocytes : Changes in two different groups of schizophrenic patients and effect of neuroleptic treatmentLife Sciences, 1983
- Are dopamine receptors present on human lymphocytes?Journal of Pharmacy and Pharmacology, 1982
- Selective labelling of murine B lymphocytes by [3H]spiroperidolJournal of Pharmacy and Pharmacology, 1981
- Decrease in lymphocyte [3H]spiroperidol binding sites in parkinsonismLife Sciences, 1980
- Identification of stereospecific [3H]spiroperidol binding sites in mammalian lymphocytesLife Sciences, 1980
- Wilson's Disease and MonoaminesArchives of Neurology, 1978
- Binding of opiates and endogenous opioid peptides to neuroleptic receptor sites in the corpus striatumLife Sciences, 1978